| Product No | EMEA/H/C/001016 |
|---|---|
| Brand Name | Iressa |
| Nonproprietary Name | gefitinib |
| API | gefitinib |
| ATC Code | L01XE02 |
| Indications | Iressa is indicated for the treatment of adult patients with locally advanced or metastatic non-small-cell lung cancer with activating mutations of epidermal-growth-factor-receptor tyrosine kinase., |
| Orphan Drug | no |
| Generics | no |
| Marketing Authorization Holder | AstraZeneca AB |
| Status | Authorised(授权) |
| Authorization Date | 2009-06-24 |
| Version | 15 |
| Condition Approval | no |
| Exceptions | no |
| Biosimilar | no |
| Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information